 |
|
|
Randall A. Lipps founded Omnicell in
September 1992 and serves as the company's chairman, president and chief executive
officer. From the company's founding until October 2002, Mr. Lipps was chairman of
the board of directors. He assumed the additional role of president and chief executive
officer in October 2002 and has provided the leadership for Omnicell's business expansion.
Since taking on the day-to-day operations of the company, Mr. Lipps has brought in a well-known
Silicon Valley management team and has focused the company on growth and technology leadership.
During 2003, Omnicell was recognized as one of the top 150 Silicon Valley companies, as measured
by market capitalization, by the San Jose Mercury News.
Prior to founding Omnicell, Mr. Lipps served as the senior vice president at ST Holdings, a travel
and marketing company. Mr. Lipps received both a B.S. in economics and a B.B.A. from Southern Methodist
University.
Mary E. Foley has served as a director of Omnicell since
May 2005. Ms.
Foley is the associate director of the Center for Research and
Innovation in Patient Care at the University of California, San
Francisco School of Nursing. Formerly the president of both the
American
Nurses Association and the California Nurses Association, Ms. Foley
has
more than 30 years of experience in patient care and nursing
education.
She worked as a staff nurse and director of nursing at Saint Francis
Memorial Hospital in San Francisco for nearly 20 years and has been
a
member of the clinical and graduate faculty at the San Francisco
State
University School of Nursing. In addition, Ms. Foley serves on the
advisory board of the Partnership for Patient Safety and the board
of
directors of the National Patient Safety Foundation. Ms. Foley has a
diploma in nursing from the New England Deaconess Hospital School of
Nursing, a B.S. degree in nursing from the Boston University School
of
Nursing, and a M.S. degree in nursing administration and
occupational
health from the University of California, San Francisco School of
Nursing.
James T. Judson
has served as a director of Omnicell since April 2006.
Mr. Judson served as Omnicell's vice president, corporate
development
until July 2006. Mr. Judson joined Omnicell in February 2005 as vice
president, finance and was later appointed executive vice president,
finance and chief financial officer in April 2005, serving in that
position until March 2006. Mr. Judson has over 20 years of financial
management experience, most of it with Sun Microsystems, Inc., a
computer software and platform company. Mr. Judson served a vice
president of finance and planning for the worldwide operations group
of
Sun Microsystems from 1998 until his retirement from the company in
January 2002. Mr. Judson received a B.S. degree in industrial
management
from Purdue University and an M.B.A. in finance from Indiana
University.
Randy Lindholm has served as a director of Omnicell since May 2003.
From June 1999 to April 2002, Mr. Lindholm was the chairman, president and CEO of VidaMed, Inc., a maker
of minimally invasive medical device products that treat the urological condition of benign prostatic
hyperplasia. From August 1998 to June 1999, Mr. Lindholm served as executive vice president, sales and
marketing, for VidaMed. From 1993 to 1998, Lindholm held senior field operations positions at Nellcor
Puritan Bennett, a provider of solutions to diagnose, monitor and treat the respiratory-impaired patient.
Mr. Lindholm began his career in 1977 with GE Medical Systems, serving in a variety of increasingly senior
sales positions. When he left GE Medical Systems in 1993, he was the west region product sales manager.
Lindholm holds a B.S. degree in electrical engineering from Michigan Tech University. He serves on the
boards of directors for Microvention, Inc., BARRx, Inc., and Rita Medical Systems, Inc.
Gary S. Petersmeyer has served as a director of Omnicell since January 2007.
Mr. Petersmeyer is the chairman and chief executive officer of Aesthetic
Sciences Corporation, a research-based medical device company focusing on
elective surgery applications. Prior to joining Aesthetic Sciences
Corporation in 2004, from 2002 to 2004 Mr. Petersmeyer provided consulting
and executive coaching services to senior executives in high-growth and
research-based organizations. From 2000 to 2001, Mr. Petersmeyer was
president and a director of Pherin Pharmaceuticals. From 1995 to 2000, he was
president, CEO and a director of Collagen Corporation, a medical technology
company focused on worldwide collagen research. Prior to 1995, Mr.
Petersmeyer held several senior executive positions at Syntex Corporation,
Beta Phase, Inc., and Coopervision, Inc. He currently serves on the boards of
directors of Percys, Inc. and RoxRo Pharmaceuticals Mr. Petersmeyer has a
Bachelor of Arts degree in political science from Stanford University, a
Master of Arts degree in teaching from the Harvard Graduate School of
Education, and a Master of Business Administration degree from Harvard
University.
Donald C. Wegmiller, Chairman of the Healthcare Group of Clark Consulting,
a firm with expertise in executive compensation and benefit design, financing and plan administration,
has been a director of Omnicell since May 2004. Prior to joining Clark Consulting's Healthcare Group,
he served as Vice President and President of HealthSpan Health Systems Corporation, Minnesota's largest
healthcare network. From 1986 to 1988, Mr. Wegmiller served as a chairman officer of the American Hospital
Association, serving in 1987 as the organization's chairman, the highest elected office. He also has been
named a Fellow in the American College of Healthcare Executives. Mr. Wegmiller received both his bachelor's
degree and master's degree in health administration from the University of Minnesota.
Sara J. White has served as a director of Omnicell since April 2003.
Ms. White is a clinical professor in the School of Pharmacy at the University of California-San Francisco.
Previously, she served as director of pharmacy and administrative director for clinical nutrition at Stanford
Hospital and Clinics. From 1993 to 1999, Ms. White was program director in an American Society of Health-System
Pharmacists (ASHP) accredited specialty residency in hospital pharmacy administration. She received a B.S. degree
from Oregon State University and a M.S. in hospital pharmacy management from Ohio State University. Ms. White
is a fellow of ASHP.
Joseph E. Whitters, vice president, finance and chief financial officer for
First Health, a $2.5 billion market capitalization managed healthcare company serving the group health, workers
compensation and state agency markets, has been a director of Omnicell since May 2003. Mr. Whitters has almost
twenty years of experience in senior financial management positions for healthcare corporations. Prior to joining
First Health in 1986, he served as controller for the largest subsidiary of United HealthCare Corp. Mr. Whitters
holds a bachelor of arts degree in accounting from Luther College.
William H. Younger, Jr. has served as a director of Omnicell since September
1992. Mr. Younger is a managing director of Sutter Hill Ventures, a venture capital firm, where he has been
employed since 1981. Mr. Younger holds a B.S. in electrical engineering from the University of Michigan and a
M.B.A. from Stanford University. Mr. Younger is also a director of Cardica, Inc. and
several privately held companies.
|
|
